Abstract
Based on the fact that human pancreas has thyrotropin-releasing hormone (TRH) immunoreactivity and bioactivity, we studied the effect of TRH on peripheral plasma levels of pancreatic glucagon (IRG) and insulin (IRI) in healthy subjects. During the infusion of 400 μg TRH for 120 min basal plasma IRI and IRG levels did not change significantly. In addition, intravenous infusion of 400 μg TRH did not affect the increments in the plasma IRG levels and the decrements in the blood glucose during insulin hypoglycemia.
| Original language | English |
|---|---|
| Pages (from-to) | 256-259 |
| Number of pages | 4 |
| Journal | Hormone and Metabolic Research |
| Volume | 18 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 1986 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Lack of effect of thyrotropin-releasing hormone (TRH) on the peripheral plasma levels of pancreatic glucagon in man'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver